We’re presenting at the upcoming Founder’s Longevity Forum, produced by Founders Forum Group, Longevity.Technology and NUS Academy for Healthy Longevity, taking place February 27-28 in Singapore. Our CEO, Jerry McLaughlin, will share insights regarding the return on investment in aging biotechnology. Learn more here: https://bit.ly/3DcvUpF
关于我们
Life Biosciences is dedicated to developing novel therapies to extend healthy human lifespan by targeting the biological causes of aging. Founded in 2017 and headquartered in Boston, MA, we are pursuing therapies targeting three molecular pathways that regulate the biology of aging: mitochondrial uncoupling, chaperone-mediated autophagy, and epigenetic reprogramming. Our platform approach enables us to develop medicines with the potential to prevent, treat, and/or reverse multiple aging-related diseases, each with critical unmet needs.
- 网站
-
https://www.lifebiosciences.com
Life Biosciences的外部链接
- 所属行业
- 生物技术
- 规模
- 11-50 人
- 总部
- Boston，Massachusetts
- 类型
- 私人持股
- 创立
- 2017
- 领域
- Healthspan、Aging Research、Longevity Research、Biotechnology、Aging、Age-Related Diseases和Biology of Aging
地点
-
主要
获取路线
75 Park Plaza
US，Massachusetts，Boston，02116
Life Biosciences员工
动态
-
We had a wonderful time speaking and connecting with other industry leaders at the 2025 Global Healthspan Summit, hosted by Hevolution Foundation. We were honored to participate in panel discussions and share our progress in advancing our Partial Epigenetic Reprogramming Platform for treating age-related disease. Thank you for a great meeting!
-
-
Don’t miss our CEO, Jerry McLaughlin, and CSO, Sharon Rosenzweig-Lipson's panels at the 2025 Global Healthspan Summit, hosted by the Hevolution Foundation. They will be sharing insights on advancing drug discovery to improve healthspan and address age-related diseases. Watch the event live here: https://bit.ly/4jHDeKy
-
We’ll be attending the upcoming Hevolution Foundation's Global HealthSpan Summit on February 4-5 in Riyadh, Saudi Arabia. We’re excited to connect with industry leaders to discuss the latest efforts to extend healthy human lifespan and understand the process of aging. Learn more here: https://bit.ly/40WCnye
-
-
Join us in welcoming Michael Ringel as our Chief Operating Officer. Through his experience, Dr. Ringel brings visionary leadership, strategic insights, and extensive industry knowledge as we advance our Cellular Rejuvenation therapies into the clinic and expand the potential of our Partial Epigenetic Reprogramming platform approach. Read more here: https://bit.ly/3PSr4kc
-
-
As we kick off 2025, our CEO, Jerry McLaughlin, was featured in a recent The Medicine Maker ‘Future of Pharma’ article where he shared his perspective on therapeutic areas to watch. He highlights #CellularRejuvenation and the promise of #EpigeneticReprogramming to alter the landscape of medicine and human health. Read more here: https://bit.ly/3Q8AYOV
-
-
January is #GlaucomaAwarenessMonth—a time to spotlight a condition affecting over 80 million people worldwide. At Life Biosciences, we’re committed to addressing conditions like #glaucoma by developing therapies to improve vision and treat #AgeRelatedDisease. Click here to learn more and find helpful resources: https://bit.ly/4fdhYIQ
-
-
We’re honored to be featured in?Labiotech.eu’s article for 10 #biotech companies to watch in 2025! At Life Bio, we’re committed to developing treatments for #AgeRelatedDiseases using #PartialEpigeneticReprogramming, with some exciting updates coming next year. Read the article here???
Last year, we documented nine biotechs we thought you should watch in 2024. Now, it’s time for 2025’s top picks! ???? As 2024 has flown by, biotech companies will be setting out their plans for next year as they continue to work towards bringing their innovative therapies through the clinic and to the market in an attempt to bring new and groundbreaking medicines to patients suffering from debilitating diseases. ???? From Wave Life Sciences to TG Therapeutics, Inc., check out our latest article to see which 10 companies we think you should keep an eye out for next year! ??? https://lnkd.in/d5QsXgbi #biotech2025 #topbiotechs #innovativetherapies #breakthroughmedicine #biotechtrends #healthcareinnovation #biotechfuture Anavex Life Sciences | Candid Therapeutics | Enterprise Therapeutics | Jazz Pharmaceuticals | Life Biosciences | Ovid Therapeutics | Skye Bioscience Inc. | Quotient Therapeutics
-
Our CEO, Jerry McLaughlin, recently joined Matthew Pillar and Forge Biologics' CEO, John Maslowski on Bioprocess Online's recent #BusinessOfBiotech podcast series. Tune in as they highlight how the strong foundation of our manufacturing relationship has ensured collaborative success in advancing biological therapeutic development. Watch here: https://bit.ly/41vuGQ6
-
-
Our CSO, Sharon Rosenzweig-Lipson, Ph.D., was recognized for presenting one of the best posters at #AAO2024! She discussed our work on #PartialEpigeneticReprogramming in a model of #NAION. Congratulations, Sharon!
-